Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling


Autoria(s): Cooper, Alasdair C; Fleming, Ian N; Phyu, Su M; Smith, Timothy A D
Contribuinte(s)

University of Aberdeen, Medicine, Medical Sciences & Nutrition, Applied Medicine

University of Aberdeen, School of Medical Sciences

Data(s)

05/08/2016

05/08/2016

01/09/2015

20/09/2001

Resumo

Peer reviewed

Postprint

Formato

10

Identificador

Cooper , A C , Fleming , I N , Phyu , S M & Smith , T A D 2015 , ' Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling ' Journal of Cancer Research and Clinical Oncology , vol 141 , no. 9 , pp. 1523-1532 . DOI: 10.1007/s00432-015-1909-2

0171-5216

PURE: 46579367

PURE UUID: 4f2ddf26-80b9-4186-a738-2b3b43d03da3

PubMed: 25579456

http://hdl.handle.net/2164/6358

http://dx.doi.org/10.1007/s00432-015-1909-2

Idioma(s)

eng

Relação

Journal of Cancer Research and Clinical Oncology

Direitos

The final publication is available at Springer via http://dx.doi.org/10.1007/s00432-015-1909-2

Palavras-Chave #metformin #breast cancer #HER2 #[18F]FDG #doxorubicin #RC Internal medicine #RC
Tipo

Journal article